Core Viewpoint - The comparison between Regeneron (REGN) and Illumina (ILMN) indicates that REGN presents a better value opportunity for investors at this time due to its stronger earnings outlook and more attractive valuation metrics [1][3][7]. Valuation Metrics - REGN has a Zacks Rank of 1 (Strong Buy), while ILMN has a Zacks Rank of 3 (Hold), suggesting a stronger improvement in REGN's earnings outlook [3]. - REGN's forward P/E ratio is 17.17, significantly lower than ILMN's forward P/E of 30.42, indicating that REGN may be undervalued relative to ILMN [5]. - The PEG ratio for REGN is 1.56, compared to ILMN's PEG ratio of 2.56, further supporting REGN's valuation attractiveness [5]. - REGN's P/B ratio stands at 2.56, while ILMN's P/B ratio is much higher at 9.88, reinforcing the notion that REGN is a better value stock [6]. - REGN has been assigned a Value grade of B, whereas ILMN has a Value grade of C, highlighting the relative valuation strength of REGN [6]. Investment Conclusion - Given the stronger estimate revision activity and more favorable valuation metrics, value investors are likely to favor REGN over ILMN as the superior investment option at this time [7].
REGN or ILMN: Which Is the Better Value Stock Right Now?